Atlas Trials

Study to Evaluate the Efficacy and Safety of FOLFIRI-AD in Patients With Metastatic Colorectal Cancer UGT1A Genotype 1

Clinical trial NCT01639326 · UNKNOWN

Trial details

NCT number
NCT01639326
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2012-07-01
Primary completion
2018-07-01
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.